- Home
- BIRD vs EPRX Comparison
BIRD vs EPRX Comparison
Compare BIRD & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRD
- EPRX
- Stock Information
- Founded
- BIRD 2015
- EPRX 2011
- Country
- BIRD United States
- EPRX Canada
- Employees
- BIRD N/A
- EPRX N/A
- Industry
- BIRD Apparel
- EPRX
- Sector
- BIRD Consumer Discretionary
- EPRX
- Exchange
- BIRD Nasdaq
- EPRX NYSE
- Market Cap
- BIRD 87.0M
- EPRX 85.5M
- IPO Year
- BIRD 2021
- EPRX N/A
- Fundamental
- Price
- BIRD $8.39
- EPRX $2.90
- Analyst Decision
- BIRD Hold
- EPRX
- Analyst Count
- BIRD 4
- EPRX 0
- Target Price
- BIRD $21.50
- EPRX N/A
- AVG Volume (30 Days)
- BIRD 91.5K
- EPRX 19.0K
- Earning Date
- BIRD 11-06-2024
- EPRX 11-07-2024
- Dividend Yield
- BIRD N/A
- EPRX N/A
- EPS Growth
- BIRD N/A
- EPRX N/A
- EPS
- BIRD N/A
- EPRX N/A
- Revenue
- BIRD $205,895,000.00
- EPRX N/A
- Revenue This Year
- BIRD N/A
- EPRX N/A
- Revenue Next Year
- BIRD N/A
- EPRX N/A
- P/E Ratio
- BIRD N/A
- EPRX N/A
- Revenue Growth
- BIRD N/A
- EPRX N/A
- 52 Week Low
- BIRD $7.65
- EPRX $2.20
- 52 Week High
- BIRD $29.00
- EPRX $3.79
- Technical
- Relative Strength Index (RSI)
- BIRD 32.04
- EPRX N/A
- Support Level
- BIRD $7.65
- EPRX N/A
- Resistance Level
- BIRD $8.59
- EPRX N/A
- Average True Range (ATR)
- BIRD 0.72
- EPRX 0.00
- MACD
- BIRD -0.25
- EPRX 0.00
- Stochastic Oscillator
- BIRD 13.53
- EPRX 0.00
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.